Cargando…

Evaluation of ABCA1 gene polymorphism as a prognostic index of fibrosis progression in NAFLD patients

INTRODUCTION: It had been evident that non‐alcoholic fatty liver disease (NAFLD) is the new era epidemic. Despite emergence of many drugs on the pipeline that considered candidates to cure NAFLD/NASH, the critical need for defining the cohort liable to fibrosis progression is yet unmet. AIM: Evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghanem, Samar E., Elsabaawy, Maha M., Abdelkareem, Mervat M., Helal, Marwa L., Othman, Warda, Elsayed, Mahitab, Elsabaawy, Dalia M., El Fert, Ashraf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836255/ https://www.ncbi.nlm.nih.gov/pubmed/36444680 http://dx.doi.org/10.1002/edm2.394

Ejemplares similares

Impact of intermittent fasting on laboratory, radiological, and anthropometric parameters in NAFLD patients
por: Badran, Hanaa, et al.
Publicado: (2022)

A case report of COVID-19 evoked cholangitic liver abscess
por: Alhaddad, Omkolsoum, et al.
Publicado: (2022)

FIB-5 versus FIB-4 index for assessment of hepatic fibrosis in chronic hepatitis B affected patients
por: Metwally, Khaled, et al.
Publicado: (2020)

Prevalence and predictors of post-liver transplantation metabolic bone diseases
por: Elsabaawy, Maha, et al.
Publicado: (2021)

Janus Kinase-2 Mutation Associated Portal Vein Thrombosis Complicating Liver Cirrhosis and Hepatocellular Carcinoma
por: Rabie, Hatem, et al.
Publicado: (2021)

Presentations, Causes and Outcomes of Drug-Induced Liver Injury in Egypt
por: Alhaddad, Omkolthoum, et al.
Publicado: (2020)

Evaluation of different diagnostic modalities of minimal hepatic encephalopathy in cirrhotic patients: case-control study
por: Salman, Tary, et al.
Publicado: (2021)

The Role of Monocyte/Macrophage and CXCR3 in Differentiation between Recurrent Hepatitis C and Acute Cellular Rejection Postliver Transplantation
por: Gomaa, Asmaa Ibrahim, et al.
Publicado: (2018)

CD62P (P-selectin) expression as a platelet activation marker in patients with liver cirrhosis with and without cholestasis
por: Hegazy, Sara, et al.
Publicado: (2021)

Baseline Sarcopenia is Associated with Lack of Response to Therapy, Liver Decompensation and High Mortality in Hepatocellular Carcinoma Patients
por: Badran, Hanaa, et al.
Publicado: (2020)

Role of liver biopsy in management of liver diseases without hepatic nodules following end of the interferon era: experience of a tertiary referral center
por: Ehsan, Nermine A., et al.
Publicado: (2022)

miRNA-451a and miRNA-125a Expression Levels in Ankylosing Spondylitis: Impact on Disease Diagnosis, Prognosis, and Outcomes
por: Fotoh, Dina Salem, et al.
Publicado: (2020)

Altered Protein and Gene Expression of Beclin-1 Correlates with Poor Prognosis of Hcv-Associated Hepatocellular Carcinoma in Egyptian Patients
por: Ehsan, Nermine Ahmed, et al.
Publicado: (2021)

MELD-Sarcopenia is Better than ALBI and MELD Score in Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation
por: Alsebaey, Ayman, et al.
Publicado: (2021)

The impact of paracentesis flow rate in patients with liver cirrhosis on the development of paracentesis induced circulatory dysfunction
por: Elsabaawy, Maha Mohammad, et al.
Publicado: (2015)

Urine Neutrophil Gelatinase-Associated Lipocalin a Possible Diagnostic Marker for Egyptian Hepatocellular Carcinoma Patients
por: Abdelsameea, Eman, et al.
Publicado: (2020)

Role of resistin, IL-6 and NH2-terminal portion proBNP in the pathogenesis of cardiac disease in type 2 diabetes mellitus
por: Ghanem, Samar Ebrahim, et al.
Publicado: (2020)

Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt
por: Tomah, Shaheen, et al.
Publicado: (2021)

Peripheral perfusion index as a predictor of failed weaning from mechanical ventilation
por: Lotfy, Ahmed, et al.
Publicado: (2020)

Fibrosis‐4 Index as an Independent Predictor of Mortality and Liver‐Related Outcomes in NAFLD
por: Vieira Barbosa, Joana, et al.
Publicado: (2021)

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease
por: Nobili, Valerio, et al.
Publicado: (2009)

BioFire FilmArray BCID2 versus VITEK-2 System in Determining Microbial Etiology and Antibiotic-Resistant Genes of Pathogens Recovered from Central Line-Associated Bloodstream Infections
por: El Sherif, Heba M., et al.
Publicado: (2022)

Imaging biomarkers of NAFLD, NASH, and fibrosis
por: Ajmera, Veeral, et al.
Publicado: (2021)

Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
por: Bazick, Jessica, et al.
Publicado: (2015)

Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness
por: Liebig, Stephanie, et al.
Publicado: (2019)

Risk of severe illness of COVID‐19 patients with NAFLD and increased NAFLD fibrosis scores
por: Yao, Renling, et al.
Publicado: (2021)

Prognostic accuracy of FIB‐4, NAFLD fibrosis score and APRI for NAFLD‐related events: A systematic review
por: Lee, Jenny, et al.
Publicado: (2021)

Cellular and Molecular Mechanisms of Liver Fibrosis in Patients with NAFLD
por: Sanchez, Jessica I., et al.
Publicado: (2023)

Diagnostic performance of the fibrosis-4 index and the NAFLD fibrosis score for screening at-risk individuals in a health check-up setting
por: Park, Huiyul, et al.
Publicado: (2023)

Hepatic artery resistive index as surrogate marker for fibrosis progression in NAFLD patients: A clinical perspective
por: Tana, Claudio, et al.
Publicado: (2018)

Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
por: Reinson, Tina, et al.
Publicado: (2023)

Subretinal Fibrosis in Stargardt's Disease with Fundus Flavimaculatus and ABCA4 Gene Mutation
por: Rossi, Settimio, et al.
Publicado: (2012)

Direct Relationship between Interleukin-10 Gene Polymorphism and Hepatocellular Carcinoma Complicated by Direct Acting Antiviral Treatment of Hepatitis C Virus
por: Ghanem, Samar Ebrahim, et al.
Publicado: (2021)

Circulatory Endothelin 1-Regulating RNAs Panel: Promising Biomarkers for Non-Invasive NAFLD/NASH Diagnosis and Stratification: Clinical and Molecular Pilot Study
por: Albadawy, Reda, et al.
Publicado: (2021)

PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients with histopathologically-confirmed NAFLD
por: Akuta, Norio, et al.
Publicado: (2021)

Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index–related parameters
por: Xue, Yan, et al.
Publicado: (2022)

Hepatocyte ABCA1 deficiency is associated with reduced HDL sphingolipids
por: Othman, Alaa, et al.
Publicado: (2023)

Sex and Menopause Modify the Effect of Single Nucleotide Polymorphism Genotypes on Fibrosis in NAFLD
por: Wegermann, Kara, et al.
Publicado: (2021)

Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD
por: Pearce, Steven G, et al.
Publicado: (2013)

Novel Algorithm for Non-Invasive Assessment of Fibrosis in NAFLD
por: Sowa, Jan-Peter, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_u647br7hqcv71ms7mqv3k45fsf